# US 2017/0283470 A1 · Mutant csgg pores

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283470 A1
- Document ID: US20170283470A1
- Status: Published application
- Kind: A1
- Application number: 15/507,947
- Filed: 2015-09-01
- Published: 2017-10-05
- Earliest claimed: 2014-09-01
- Assignees: Oxford Nanopore Technologies PLC; Vib Vzw; Vrije Universiteit Brussel
- Applicants: Oxford Nanopore Technologies Ltd.; Vib Vzw; Vrije Universiteit Brussel
- Inventors: Stefan Howorka; Han Remaut; Lakmal Jayasinghe; Elizabeth Jayne Wallace; James Anthony Clarke; Richard George Hambley; Jonathan Bankes Pugh
- Web page: https://patentgrep.com/patent/US20170283470A1

## CPC

- C07K 14/245: Escherichia (G)
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- G01N 27/447: using electrophoresis
- C07K 2319/22: containing a Strep-tag
- C12Q 1/68: involving nucleic acids
- C12Q 2565/631: being a biochannel or pore
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to mutant forms of the outer membrane located lipoprotein CsgG, in particular, modifications at one or more of positions Tyr51; Asn55; and Phe56. The invention also relates to analyte detection and characterisation using said mutant CsgG.

## Claims

### Claim 1

At least one modified CsgG monomer wherein the monomer comprises a modification at one or more of positions Tyr51 ; Asn55; and Phe56.

### Claim 2 (depends on 1)

A modified biological pore comprising the at least one CsgG monomer of claim 1.

### Claim 3

A modified CsgG biological pore comprising at least one CsgG monomer, wherein the modified CsgG biological pore has no more than one channel constriction with a diameter in the range from 0.5 nm to 1.5 nm.

### Claim 4 (depends on 3)

The modified pore of claim 3, wherein the modification is between positions 38 to 63 of the CsgG monomeric polypeptide sequence.

### Claim 5 (depends on 4)

The modified pore of claim 4, wherein the modification is at a position selected from: Tyr51; Asn55; and Phe 56.

### Claim 6 (depends on 5)

The modified pore of claim 5, wherein the modification is at position Tyr 51, or at both of positions Asn55 and Phe56.

### Claim 7 (depends on 3)

The modified pore of claim 3, wherein the modification to the CsgG monomer is selected from the group consisting of substitution of the naturally occurring amino acid; deletion of the naturally occurring amino acid; and modification of the naturally-occurring amino acid side chain.

### Claim 8 (depends on 3)

The modified pore of claim 3, wherein the modification reduces or removes the steric encumbrance of the unmodified amino acid.

### Claim 9 (depends on 3)

The modified pore of claim 3, wherein the at least one CsgG monomer of the modified pore has a polypeptide sequence from positions 38 to 63 according to SEQ ID Nos: 4to 388.

### Claim 10 (depends on 3)

An isolated polypeptide encoding the at least one CsgG monomer of the modified CsgG biological pore of claim 3.

### Claim 11 (depends on 10)

The isolated nucleic acids encoding the isolated polypeptides of claim 10.

### Claim 12

A biosensor comprising:
a) an insulating layer;
b) a CsgG biological pore within the insulating layer; and
c) apparatus for measuring an electrical current through the biological pore.

### Claim 13 (depends on 3, 12)

The biosensor of claim 12, wherein the CsgG biological pore is a modified CsgG biological pore according to claim 3.

### Claim 14

Use of a CsgG biological pore for biological sensing applications, wherein the biological sensing application is analyte detection or nucleic acid sequencing.

### Claim 15 (depends on 14)

The use of claim 14, wherein the nucleic acid sequencing is DNA sequencing or RNA sequencing.

### Claim 16

A method for molecular sensing comprising:
a) providing a CsgG biological pore formed of at least one CsgG monomer within an insulating layer;
b) allowing the CsgG biological pore to interact with a test substrate; and
c) taking one or more measurements during the interaction.

### Claim 17 (depends on 16)

method of claim 16 wherein the method comprises:
a) providing a CsgG biological pore formed of at least one CsgG monomer within an insulating layer;
b) applying an electrical potential across the insulating layer thereby establishing flow of electrical current through the biological pore;
c) contacting the CsgG biological pore with a test substrate; and
d) measuring the electrical current flow through the biological pore.

### Claim 18 (depends on 16)

The method of claim 16, wherein the insulating layer is a membrane.

### Claim 19 (depends on 18)

The method of claim 18, wherein the membrane is a lipid bilayer.

### Claim 20 (depends on 17)

The method of claim 17, wherein the electrical current through the pore is carried by a flow of soluble ions from a first side of the insulating layer to the second side of the insulating layer.

### Claim 21 (depends on 16)

The method of claim 16, wherein the molecular sensing is analyte detection.

### Claim 22 (depends on 17)

The method of claim 17, wherein the method comprises after step (d) the further step of determining the presence of the test substrate by a reduction in electrical current through the biological pore compared to the electrical current through the biological pore when the test substrate is absent.

### Claim 23 (depends on 16)

The method of claim 16, wherein the molecular sensing is nucleic acid sequencing.

### Claim 24 (depends on 23)

The method of claim 23, wherein the type of nucleic acid sequenced by said method is DNA or RNA.

### Claim 25 (depends on 23)

The method of claim 23, wherein the CsgG biological pore is adapted to accommodate additional accessory proteins.

### Claim 26 (depends on 25)

The method of claim 25, wherein the additional accessory proteins are nucleic acid-processing enzymes selected from the group consisting of: DNA or RNA polymerases; isomerases; topoisomerases; gyrases; telomerases; exonucleases; and helicases.

### Claim 27 (depends on 16)

The method of claim 16, wherein the CsgG biological pore is a modified CsgG pore, wherein the modified CsgG pore has at least one modification to the monomeric wild-type E-coli CsgG polypeptide sequence in at least one of the CsgG monomers forming the CsgG pore.

### Claim 28 (depends on 27)

The method of claim 27, wherein the same modification is made to all the CsgG monomers forming the CsgG pore.

### Claim 29 (depends on 27)

The method of claim 27, wherein the modified CsgG monomer has a polypeptide sequence from positions 38 to 63 according to SEQ ID Nos: 4 to 388.

### Claim 30

A mutant CsgG monomer comprising a variant of the sequence shown in SEQ ID NO: 390, wherein the variant comprises a mutation at one or more of positions Y51, N55 and F56.

### Claim 31

A mutant CsgG monomer comprising a variant of the sequence shown in SEQ ID NO: 390, wherein the variant comprises one or more of the following: (i) one or more mutations at the following positions N40, D43, E44, S54, S57, Q62, R97, E101, E124, E131, R142, T150 and R192; (ii) mutations at Y51/N55, Y51/F56, N55/F56 or Y51/N55/F56; (iii) Q42R or Q42K; (iv) K49R; (v) N102R, N102F, N102Y or N102W; (vi) D149N, D149Q or D149R; (vii) E185N, E185Q or E185R; (viii) D195N, D195Q or D195R; (ix) E201N, E201Q or E201 R; (x) E203N, E203Q or E203R; and (xi) deletion of one or more of the following positions F48, K49, P50, Y51, P52, A53, S54, N55, F56 and S57.

### Claim 32 (depends on 31)

A mutant monomer according to claim 31 , wherein
(a) the variant comprises in (i) one or more of the following substitutions N40R, N40K, D43N, D43Q, D43R, D43K, E44N, E44Q, E44R, E44K, S54P, S57P, Q62R, Q62K, R97N, R97G, R97L, E101 N, E101Q, E101R, E101 K, E101 F, E101Y, E101W, E124N, E124Q, E124R, E124K, E124F, E124Y, E124W, E131 D, R142E, R142N, T150I, R192E and R192N;
(b) the variant comprises in (ii) F56N/N55Q, F56N/N55R, F56N/N55K, F56N/N55S, F56N/N55G, F56N/N55A, F56N/N55T, F56Q/N55Q, F56Q/N55R, F56Q/N55K, F56Q/N55S, F56Q/N55G, F56Q/N55A, F56Q/N55T, F56R/N55Q, F56R/N55R, F56R/N55K, F56R/N55S, F56R/N55G, F56R/N55A, F56R/N55T, F56S/N55Q, F56S/N55R, F56S/N55K, F56S/N55S, F56S/N55G, F56S/N55A, F56S/N55T, F56G/N55Q, F56G/N55R, F56G/N55K, F56G/N55S, F56G/N55G, F56G/N55A, F56G/N55T, F56A/N55Q, F56A/N55R, F56A/N55K, F56A/N55S, F56A/N55G, F56A/N55A, F56A/N55T, F56K/N55Q, F56K/N55R, F56K/N55K, F56K/N55S, F56K/N55G, F56K/N55A, F56K/N55T, F56N/Y51L, F56N/Y51V, F56N/Y51A, F56N/Y51N, F56N/Y51Q, F56N/Y51S, F56N/Y51G, F56Q/Y51L, F56Q/Y51V, F56Q/Y51A, F56Q/Y51N, F56Q/Y51Q, F56Q/Y51S, F56Q/Y51G, F56R/Y51L, F56R/Y51V, F56R/Y51A, F56R/Y51N, F56R/Y51Q, F56R/Y51S, F56R/Y51G, F56S/Y51L, F56S/Y51V, F56S/Y51A, F56S/Y51N, F56S/Y51Q, F56S/Y51S, F56S/Y51G, F56G/Y51L, F56G/Y51V, F56G/Y51A, F56G/Y51N, F56G/Y51Q, F56G/Y51S, F56G/Y51G, F56A/Y51L, F56A/Y51V, F56A/Y51A, F56A/Y51N, F56A/Y51Q, F56A/Y51S, F56A/Y51G, F56K/Y51L, F56K/Y51V, F56K/Y51A, F56K/Y51N, F56K/Y51Q, F56K/Y51S, F56K/Y51G, N55Q/Y51L, N55Q/Y51V, N55Q/Y51A, N55Q/Y51N, N55Q/Y51Q, N55Q/Y51S, N55Q/Y51G, N55R/Y51L, N55R/Y51V, N55R/Y51A, N55R/Y51N, N55R/Y51Q, N55R/Y51S, N55R/Y51G, N55K/Y51L, N55K/Y51V, N55K/Y51A, N55K/Y51N, N55K/Y51Q, N55K/Y51S, N55K/Y51G, N55S/Y51L, N55S/Y51V, N55S/Y51A, N55S/Y51N, N55S/Y51Q, N55S/Y51S, N55S/Y51G, N55G/Y51L, N55G/Y51V, N55G/Y51A, N55G/Y51N, N55G/Y51Q, N55G/Y51S, N55G/Y51G, N55A/Y51L, N55A/Y51V, N55A/Y51A, N55A/Y51N, N55A/Y51Q, N55A/Y51S, N55A/Y51G, N55T/Y51L, N55T/Y51V, N55T/Y51A, N55T/Y51N, N55T/Y51Q, N55T/Y51S, N55T/Y51G, F56N/N55Q/Y51L, F56N/N55Q/Y51V, F56N/N55Q/Y51A, F56N/N55Q/Y51N, F56N/N55Q/Y51Q, F56N/N55Q/Y51S, F56N/N55Q/Y51G, F56N/N55R/Y51L, F56N/N55R/Y51V, F56N/N55R/Y51A, F56N/N55R/Y51N, F56N/N55R/Y51Q, F56N/N55R/Y51S, F56N/N55R/Y51G, F56N/N55K/Y51L, F56N/N55K/Y51V, F56N/N55K/Y51A, F56N/N55K/Y51N, F56N/N55K/Y51Q, F56N/N55K/Y51S, F56N/N55K/Y51G, F56N/N55S/Y51L, F56N/N55S/Y51V, F56N/N55S/Y51A, F56N/N55S/Y51N, F56N/N55S/Y51Q, F56N/N55S/Y51S, F56N/N55S/Y51G, F56N/N55G/Y51L, F56N/N55G/Y51V, F56N/N55G/Y51A, F56N/N55G/Y51N, F56N/N55G/Y51Q, F56N/N55G/Y51S, F56N/N55G/Y51G, F56N/N55A/Y51L, F56N/N55A/Y51V, F56N/N55A/Y51A, F56N/N55A/Y51N, F56N/N55A/Y51Q, F56N/N55A/Y51S, F56N/N55A/Y51G, F56N/N55T/Y51L, F56N/N55T/Y51V, F56N/N55T/Y51A, F56N/N55T/Y51N, F56N/N55T/Y51Q, F56N/N55T/Y51S, F56N/N55T/Y51G, F56Q/N55Q/Y51L, F56Q/N55Q/Y51V, F56Q/N55Q/Y51A, F56Q/N55Q/Y51N, F56Q/N55Q/Y51Q, F56Q/N55Q/Y51S, F56Q/N55Q/Y51G, F56Q/N55R/Y51L, F56Q/N55R/Y51V, F56Q/N55R/Y51A, F56Q/N55R/Y51N, F56Q/N55R/Y51Q, F56Q/N55R/Y51S, F56Q/N55R/Y51G, F56Q/N55K/Y51L, F56Q/N55K/Y51V, F56Q/N55K/Y51A, F56Q/N55K/Y51N, F56Q/N55K/Y51Q, F56Q/N55K/Y51S, F56Q/N55K/Y51G, F56Q/N55S/Y51L, F56Q/N55S/Y51V, F56Q/N55S/Y51A, F56Q/N55S/Y51N, F56Q/N55S/Y51Q, F56Q/N55S/Y51S, F56Q/N55S/Y51G, F56Q/N55G/Y51L, F56Q/N55G/Y51V, F56Q/N55G/Y51A, F56Q/N55G/Y51N, F56Q/N55G/Y51Q, F56Q/N55G/Y51S, F56Q/N55G/Y51G, F56Q/N55A/Y51L, F56Q/N55A/Y51V, F56Q/N55A/Y51A, F56Q/N55A/Y51N, F56Q/N55A/Y51Q, F56Q/N55A/Y51S, F56Q/N55A/Y51G, F56Q/N55T/Y51L, F56Q/N55T/Y51V, F56Q/N55T/Y51A, F56Q/N55T/Y51N, F56Q/N55T/Y51Q, F56Q/N55T/Y51S, F56Q/N55T/Y51G, F56R/N55Q/Y51L, F56R/N55Q/Y51V, F56R/N55Q/Y51A, F56R/N55Q/Y51N, F56R/N55Q/Y51Q, F56R/N55Q/Y51S, F56R/N55Q/Y51G, F56R/N55R/Y51L, F56R/N55R/Y51V, F56R/N55R/Y51A, F56R/N55R/Y51N, F56R/N55R/Y51Q, F56R/N55R/Y51S, F56R/N55R/Y51G, F56R/N55K/Y51L, F56R/N55K/Y51V, F56R/N55K/Y51A, F56R/N55K/Y51N, F56R/N55K/Y51Q, F56R/N55K/Y51S, F56R/N55K/Y51G, F56R/N55S/Y51L, F56R/N55S/Y51V, F56R/N55S/Y51A, F56R/N55S/Y51N, F56R/N55S/Y51Q, F56R/N55S/Y51S, F56R/N55S/Y51G, F56R/N55G/Y51L, F56R/N55G/Y51V, F56R/N55G/Y51A, F56R/N55G/Y51N, F56R/N55G/Y51Q, F56R/N55G/Y51S, F56R/N55G/Y51G, F56R/N55A/Y51L, F56R/N55A/Y51V, F56R/N55A/Y51A, F56R/N55A/Y51N, F56R/N55A/Y51Q, F56R/N55A/Y51S, F56R/N55A/Y51G, F56R/N55T/Y51L, F56R/N55T/Y51V, F56R/N55T/Y51A, F56R/N55T/Y51N, F56R/N55T/Y51Q, F56R/N55T/Y51S, F56R/N55T/Y51G, F56S/N55Q/Y51L, F56S/N55Q/Y51V, F56S/N55Q/Y51A, F56S/N55Q/Y51N, F56S/N55Q/Y51Q, F56S/N55Q/Y51S, F56S/N55Q/Y51G, F56S/N55R/Y51L, F56S/N55R/Y51V, F56S/N55R/Y51A, F56S/N55R/Y51N, F56S/N55R/Y51Q, F56S/N55R/Y51S, F56S/N55R/Y51G, F56S/N55K/Y51L, F56S/N55K/Y51V, F56S/N55K/Y51A, F56S/N55K/Y51N, F56S/N55K/Y51Q, F56S/N55K/Y51S, F56S/N55K/Y51G, F56S/N55S/Y51L, F56S/N55S/Y51V, F56S/N55S/Y51A, F56S/N55S/Y51N, F56S/N55S/Y51Q, F56S/N55S/Y51S, F56S/N55S/Y51G, F56S/N55G/Y51L, F56S/N55G/Y51V, F56S/N55G/Y51A, F56S/N55G/Y51N, F56S/N55G/Y51Q, F56S/N55G/Y51S, F56S/N55G/Y51G, F56S/N55A/Y51L, F56S/N55A/Y51V, F56S/N55A/Y51A, F56S/N55A/Y51N, F56S/N55A/Y51Q, F56S/N55A/Y51S, F56S/N55A/Y51G, F56S/N55T/Y51L, F56S/N55T/Y51V, F56S/N55T/Y51A, F56S/N55T/Y51N, F56S/N55T/Y51Q, F56S/N55T/Y51S, F56S/N55T/Y51G, F56G/N55Q/Y51L, F56G/N55Q/Y51V, F56G/N55Q/Y51A, F56G/N55Q/Y51N, F56G/N55Q/Y51Q, F56G/N55Q/Y51S, F56G/N55Q/Y51G, F56G/N55R/Y51L, F56G/N55R/Y51V, F56G/N55R/Y51A, F56G/N55R/Y51N, F56G/N55R/Y51Q, F56G/N55R/Y51S, F56G/N55R/Y51G, F56G/N55K/Y51L, F56G/N55K/Y51V, F56G/N55K/Y51A, F56G/N55K/Y51N, F56G/N55K/Y51Q, F56G/N55K/Y51S, F56G/N55K/Y51G, F56G/N55S/Y51L, F56G/N55S/Y51V, F56G/N55S/Y51A, F56G/N55S/Y51N, F56G/N55S/Y51Q, F56G/N55S/Y51S, F56G/N55S/Y51G, F56G/N55G/Y51L, F56G/N55G/Y51V, F56G/N55G/Y51A, F56G/N55G/Y51N, F56G/N55G/Y51Q, F56G/N55G/Y51S, F56G/N55G/Y51G, F56G/N55A/Y51L, F56G/N55A/Y51V, F56G/N55A/Y51A, F56G/N55A/Y51N, F56G/N55A/Y51Q, F56G/N55A/Y51S, F56G/N55A/Y51G, F56G/N55T/Y51L, F56G/N55T/Y51V, F56G/N55T/Y51A, F56G/N55T/Y51N, F56G/N55T/Y51Q, F56G/N55T/Y51S, F56G/N55T/Y51G, F56A/N55Q/Y51L, F56A/N55Q/Y51V, F56A/N55Q/Y51A, F56A/N55Q/Y51N, F56A/N55Q/Y51Q, F56A/N55Q/Y51S, F56A/N55Q/Y51G, F56A/N55R/Y51L, F56A/N55R/Y51V, F56A/N55R/Y51A, F56A/N55R/Y51N, F56A/N55R/Y51Q, F56A/N55R/Y51S, F56A/N55R/Y51G, F56A/N55K/Y51L, F56A/N55K/Y51V, F56A/N55K/Y51A, F56A/N55K/Y51N, F56A/N55K/Y51Q, F56A/N55K/Y51S, F56A/N55K/Y51G, F56A/N55S/Y51L, F56A/N55S/Y51V, F56A/N55S/Y51A, F56A/N55S/Y51N, F56A/N55S/Y51Q, F56A/N55S/Y51S, F56A/N55S/Y51G, F56A/N55G/Y51L, F56A/N55G/Y51V, F56A/N55G/Y51A, F56A/N55G/Y51N, F56A/N55G/Y51Q, F56A/N55G/Y51S, F56A/N55G/Y51G, F56A/N55A/Y51L, F56A/N55A/Y51V, F56A/N55A/Y51A, F56A/N55A/Y51N, F56A/N55A/Y51Q, F56A/N55A/Y51S, F56A/N55A/Y51G, F56A/N55T/Y51L, F56A/N55T/Y51V, F56A/N55T/Y51A, F56A/N55T/Y51N, F56A/N55T/Y51Q, F56A/N55T/Y51S, F56A/N55T/Y51G, F56K/N55Q/Y51L, F56K/N55Q/Y51V, F56K/N55Q/Y51A, F56K/N55Q/Y51N, F56K/N55Q/Y51Q, F56K/N55Q/Y51S, F56K/N55Q/Y51G, F56K/N55R/Y51L, F56K/N55R/Y51V, F56K/N55R/Y51A, F56K/N55R/Y51N, F56K/N55R/Y51Q, F56K/N55R/Y51S, F56K/N55R/Y51G, F56K/N55K/Y51L, F56K/N55K/Y51V, F56K/N55K/Y51A, F56K/N55K/Y51N, F56K/N55K/Y51Q, F56K/N55K/Y51S, F56K/N55K/Y51G, F56K/N55S/Y51L, F56K/N55S/Y51V, F56K/N55S/Y51A, F56K/N55S/Y51N, F56K/N55S/Y51Q, F56K/N55S/Y51S, F56K/N55S/Y51G, F56K/N55G/Y51L, F56K/N55G/Y51V, F56K/N55G/Y51A, F56K/N55G/Y51N, F56K/N55G/Y51Q, F56K/N55G/Y51S, F56K/N55G/Y51G, F56K/N55A/Y51L, F56K/N55A/Y51V, F56K/N55A/Y51A, F56K/N55A/Y51N, F56K/N55A/Y51Q, F56K/N55A/Y51S, F56K/N55A/Y51G, F56K/N55T/Y51L, F56K/N55T/Y51V, F56K/N55T/Y51A, F56K/N55T/Y51N, F56K/N55T/Y51Q, F56K/N55T/Y51S, F56K/N55T/Y51G, F56E/N55R, F56E/N55K, F56D/N55R, F56D/N55K, F56R/N55E, F56R/N55D, F56K/N55E or F56K/N55D; and/or
(c) the variant comprises in (xi) deletion of Y51/P52, Y51/P52/A53, P50 to P52, P50 to A53, K49 to Y51, K49 to A53 and replacement with a single proline (P), K49 to S54 and replacement with a single P, Y51 to A53, Y51 to S54, N55/F56, N55 to S57, N55/F56 and replacement with a single P, N55/F56 and replacement with a single glycine (G), N55/F56 and replacement with a single alanine (A), N55/F56 and replacement with a single P and Y51 N, N55/F56 and replacement with a single P and Y51Q, N55/F56 and replacement with a single P and Y51S, N55/F56 and replacement with a single G and Y51 N, N55/F56 and replacement with a single G and Y51 Q, N55/F56 and replacement with a single G and Y51S, N55/F56 and replacement with a single A and Y51N, N55/F56 and replacement with a single A/Y51Q or N55/F56 and replacement with a single A and Y51S.

### Claim 33 (depends on 31)

A mutant according to claim 31, wherein the variant comprises D195N/E203N, D195Q/E203N, D195N/E203Q, D195Q/E203Q, E201 N/E203N, E201 Q/E203N, E201 N/E203Q, E201 Q/E203Q, E185N/E203Q, E185Q/E203Q, E185N/E203N, E185Q/E203N, D195N/E201 N/E203N, D195Q/E201 N/E203N, D195N/E201 Q/E203N, D195N/E201 N/E203Q, D195Q/E201 Q/E203N, D195Q/E201 N/E203Q, D195N/E201 Q/E203Q, D195Q/E201 Q/E203Q, D149N/E201 N, D149Q/E201 N, D149N/E201 Q, D149Q/E201 Q, D149N/E201 N/D195N, D149Q/E201 N/D195N, D149N/E201 Q/D195N, D149N/E201 N/D195Q, D149Q/E201 Q/D195N, D149Q/E201 N/D195Q, D149N/E201 Q/D195Q, D149Q/E201 Q/D195Q, D149N/E203N, D149Q/E203N, D149N/E203Q, D149Q/E203Q, D 149N/E 185N/E201 N, D149Q/E185N/E201 N, D149N/E185Q/E201 N, D149N/E185N/E201 Q, D 149Q/E 185Q/E201 N, D149Q/E185N/E201 Q, D149N/E185Q/E201 Q, D149Q/E185Q/E201 Q, D149N/E185N/E203N, D149Q/E185N/E203N, D149N/E185Q/E203N, D149N/E185N/E203Q, D149Q/E185Q/E203N, D149Q/E185N/E203Q, D149N/E185Q/E203Q, D 149Q/E185Q/E203Q, D 149N/E 185N/E201 N/E203N, D149Q/E185N/E201 N/E203N, D 149N/E 185Q/E201 N/E203N, D149N/E 185N/E201Q/E203N, D 149N/E185N/E201 N/E203Q, D 149Q/E 185Q/E201 N/E203N, D149Q/E 185N/E201Q/E203N, D149Q/E185N/E201 N/E203Q, D 149N/E 185Q/E201 Q/E203N, D149N/E185Q/E201 N/E203Q, D149N/E185N/E201 Q/E203Q, D 149Q/E 185Q/E201 Q/E203Q, D 149Q/E 185Q/E201 N/E203Q, D 149Q/E 185N/E201 Q/E203Q, D149N/E185Q/E201 Q/E203Q, D 149Q/E185Q/E201 Q/E203N, D149N/E185N/D 195N/E201 N/E203N, D 149Q/E185N/D 195N/E201 N/E203N, D149N/E185Q/D 195N/E201 N/E203N, D149N/E185N/D195Q/E201 N/E203N, D149N/E185N/D195N/E201 Q/E203N, D 149N/E 185N/D 195N/E201 N/E203Q, D149Q/E185Q/D 195N/E201 N/E203N, D 149Q/E185N/D 195Q/E201 N/E203N, D149Q/E185N/D 195N/E201 Q/E203N, D 149Q/E185N/D 195N/E201 N/E203Q, D149N/E185Q/D195Q/E201 N/E203N, D 149 N/E 185Q/D 195N/E201 Q/E203N, D149N/E185Q/D195N/E201 N/E203Q, D 149N/E 185N/D 195Q/E201 Q/E203N, D149N/E185N/D195Q/E201N/E203Q, D149N/E185N/D 195N/E201 Q/E203Q, D149Q/E185Q/D195Q/E201N/E203N, D149Q/E 185Q/D 195N/E201 Q/E203N, D149Q/E185Q/D195N/E201N/E203Q, D149Q/E185N/D 195Q/E201 Q/E203N, D149Q/E185N/D 195Q/E201 N/E203Q, D149Q/E185N/D 195N/E201 Q/E203Q, D149N/E185Q/D195Q/E201Q/E203N, D149N/E185Q/D 195Q/E201 N/E203Q, D 149N/E185Q/D 195N/E201 Q/E203Q, D149N/E 185N/D 195Q/E201 Q/E203Q, D149Q/E185Q/D195Q/E201Q/E203N, D149Q/E185Q/D 195Q/E201 N/E203Q, D149Q/E185Q/D195N/E201 Q/E203Q, D149Q/E185N/D 195Q/E201 Q/E203Q, D149N/E185Q/D195Q/E201Q/E203Q, D149Q/E 185Q/D 195Q/E201 Q/E203Q, D149N/E185R/E201 N/E203N, D149Q/E185R/E201N/E203N, D149N/E185R/E201 Q/E203N, D149N/E185R/E201 N/E203Q, D149Q/E185R/E201Q/E203N, D149Q/E185R/E201 N/E203Q, D149N/E185R/E201 Q/E203Q, D149Q/E185R/E201Q/E203Q,D149R/E185N/E201 N/E203N, D149R/E185Q/E201 N/E203N, D149R/E185N/E201Q/E203N,D149R/E185N/E201 N/E203Q, D149R/E185Q/E201 Q/E203N, D149R/E185Q/E201N/E203Q,D149R/E185N/E201 Q/E203Q, D149R/E185Q/E201 Q/E203Q, D149R/E185N/D195N/E201 N/E203N, D149R/E185Q/D195N/E201 N/E203N, D149R/E185N/D195Q/E201 N/E203N, D149R/E185N/D195N/E201 Q/E203N, D149R/E185Q/D195N/E201N/E203Q, D149R/E185Q/D195Q/E201 N/E203N, D149R/E185Q/D 195N/E201 Q/E203N, D149R/E185Q/D195N/E201 N/E203Q, D 149R/E 185N/D 195Q/E201 Q/E203N, D149R/E185N/D 195Q/E201 N/E203Q, D 149R/E 185N/D 195N/E201 Q/E203Q, D149R/E185Q/D195Q/E201Q/E203N, D 149R/E185Q/D 195Q/E201 N/E203Q, D149R/E185Q/D195N/E201Q/E203Q, D 149R/E 185N/D 195Q/E201 Q/E203Q, D149R/E185Q/D195Q/E201 Q/E203Q, D149N/E 185R/D 195N/E201 N/E203N, D149Q/E185R/D 195N/E201 N/E203N, D149N/E185R/D195Q/E201 N/E203N, D149N/E185R/D195N/E201 Q/E203N, D149N/E185R/D195N/E201 N/E203Q, D149Q/E185R/D195Q/E201 N/E203N, D149Q/E185R/D195N/E201Q/E203N, D149Q/E185R/D 195N/E201 N/E203Q, D 149N/E185R/D 195Q/E201Q/E203N, D149N/E185R/D195Q/E201 N/E203Q, D149N/E 185R/D 195N/E201 Q/E203Q, D149Q/E185R/D195Q/E201Q/E203N, D 149Q/E 185R/D 195Q/E201 N/E203Q, D149Q/E185R/D 195N/E201 Q/E203Q, D 149N/E 185R/D 195Q/E201 Q/E203Q, D149Q/E185R/D 195Q/E201 Q/E203Q, D 149N/E 185R/D 195N/E201 R/E203N, D149Q/E185R/D195N/E201 R/E203N, D149N/E185R/D195Q/E201 R/E203N, D149N/E185R/D195N/E201 R/E203Q, D 149Q/E185R/D 195Q/E201 R/E203N, D149Q/E185R/D195N/E201 R/E203Q, D 149N/E 185R/D 195Q/E201 R/E203Q, D149Q/E185R/D195Q/E201 R/E203Q, E131 D/K49R, E101 N/N102F, E101 N/N102Y, E101N/N102W, E101 F/N102F, E101 F/N102Y, E101 F/N102W, E101Y/N102F, E101Y/N102Y, E101Y/N102W, E101 W/N102F, E101W/N102Y, E101W/N102W, E101 N/N102R, E101F/N102R, E101 Y/N102R or E101W/N102F.

### Claim 34 (depends on 31)

A mutant monomer according to claim 31 wherein the variant comprises a mutation at T150.

### Claim 35 (depends on 31)

A construct comprising two or more covalently attached CsgG monomers, wherein at least one of the monomers is a mutant monomer according to claim 31.

### Claim 36 (depends on 35)

A construct according to claim 35, wherein the two or more mutant monomers are the same or different.

### Claim 37 (depends on 35)

A construct according to claim 35, wherein the two or more mutant monomers are genetically fused.

### Claim 38 (depends on 35)

A construct according to claim 35, wherein the two or more mutant monomers are attached via one or more linkers.

### Claim 39 (depends on 31, 35)

A construct according to claim 35, wherein the construct comprises two mutant monomers according to claim 31.

### Claim 40 (depends on 31, 37)

A polynucleotide which encodes a mutant monomer according to claim 31 or a construct according to claim 37.

### Claim 41 (depends on 31, 35)

A homo-oligomeric pore derived from CsgG comprising identical mutant monomers according to claim 31 or identical constructs according to claim 35.

### Claim 42 (depends on 31, 41)

A homo-oligomeric pore according to claim 41, wherein the pore comprises nine identical mutant monomers according to claim 31.

### Claim 43 (depends on 31, 35)

A hetero-oligomeric pore derived from CsgG comprising at least one mutant monomer according to claim 31 or at least one construct according to claim 35.

### Claim 44 (depends on 31, 43)

A hetero-oligomeric pore according to claim 43, wherein the pore comprises (a) nine mutant monomers according to claim 31 and wherein at least one of them differs from the others or (b) one or more mutant monomers according to claim 31 and sufficient additional monomers comprising SEQ ID NO: 390.

### Claim 45

A method for determining the presence, absence or one or more characteristics of a target analyte, comprising:
a. contacting the target analyte with a CsgG pore or a mutant thereof such that the target analyte moves with respect to the pore; and
b. taking one or more measurements as the analyte moves with respect to the pore and thereby determining the presence, absence or one or more characteristics of the analyte.

### Claim 46 (depends on 45)

A method according to claim 45, wherein the CsgG mutant comprises nine monomers and at least one of the monomers is a variant of SEQ ID NO: 390, said variant comprising: (a) mutations at one or more of the following positions N40, Q42, D43, E44, K49, Y51, S54, N55, F56, S57, Q62, E101, N102, E124, E131, R142, D149, T150, E185, R192, D195, E201 and E203; and/or (b) deletion of one or more of the following positions F48, K49, P50, Y51, P52, A53, S54, N55, F56 and S57.

### Claim 47 (depends on 46)

A method according to claim 46, wherein the variant comprises one or more of the following substitutions (a) F56N, F56Q, F56R, F56S, F56G, F56A or F56K or F56A, F56P, F56R, F56H, F56S, F56Q, F56I, F56L, F56T or F56G; (b) N55Q, N55R, N55K, N55S, N55G, N55A or N55T; (c) Y51 L, Y51V, Y51A, Y51 N, Y51 Q, Y51 S or Y51 G; (d) T150I; (e) S54P; and (f) S57P.

### Claim 48 (depends on 31, 46)

A method according to claim 46, wherein the variant comprises any of the combinations of mutations/substitutions defined in claim 31.

### Claim 49 (depends on 31, 48)

A method according to claim 48, wherein the pore is a pore according to claim 31.

### Claim 50 (depends on 45)

A method according to claim 45, wherein the target analyte is a metal ion, an inorganic salt, a polymer, an amino acid, a peptide, a polypeptide, a protein, a nucleotide, an oligonucleotide, a polynucleotide, a dye, a bleach, a pharmaceutical, a diagnostic agent, a recreational drug, an explosive or an environmental pollutant.

### Claim 51 (depends on 50)

A method according to claim 50, wherein the target analyte is a target polynucleotide.

### Claim 52 (depends on 51)

A method according to claim 51, wherein the method is for characterising a target polynucleotide and the method comprises:
a) contacting the polynucleotide with the pore such that the polynucleotide moves with respect to the pore; and
b) taking one or more measurements as the polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the polynucleotide, and thereby characterising the target polynucleotide.

### Claim 53 (depends on 52)

A method according to claim 52, wherein the one or more characteristics are selected from (i) the length of the polynucleotide, (ii) the identity of the polynucleotide, (iii) the sequence of the polynucleotide, (iv) the secondary structure of the polynucleotide and (v) whether or not the polynucleotide is modified.

### Claim 54 (depends on 52)

A method according to claim 52, wherein the one or more characteristics of the polynucleotide are measured by electrical measurement and/or optical measurement.

### Claim 55 (depends on 54)

A method according to claim 54, wherein the electrical measurement is a current measurement, an impedance measurement, a tunnelling measurement or a field effect transistor (FET) measurement.

### Claim 56 (depends on 52)

A method according to claim 52, wherein step a) further comprises contacting the polynucleotide with a polynucleotide binding protein such that the protein controls the movement of the polynucleotide through the pore.

### Claim 57 (depends on 56)

A method according to claim 56, wherein the method comprises:
a) contacting the polynucleotide with the pore and the polynucleotide binding protein such that the protein controls the movement of the polynucleotide with respect to the pore; and
b) measuring the current passing through the pore as the polynucleotide moves with respect to the pore wherein the current is indicative of one or more characteristics of the polynucleotide and thereby characterising the target polynucleotide.

### Claim 58 (depends on 56)

A method according to claim 56, wherein the polynucleotide binding protein is a helicase or is derived from a helicase.

### Claim 59 (depends on 51)

A method according to claim 51, wherein the the method is for characterising a target polynucleotide and the method comprises:
a) contacting the polynucleotide with a CsgG pore or mutant thereof and an exonucleoase such that the exonuclease digests individual nucleotides from one end of the target polynucleotide and the individual nucleotides move with respect to the pore; and
b) taking one or more measurements as the individual nucleotides move with respect to the pore, wherein the measurements are indicative of one or more characteristics of the individual nucleotides, and thereby characterising the target polynucleotide.

### Claim 60 (depends on 45)

A method according to claim 45, wherein the pore is in a membrane.

### Claim 61 (depends on 60)

A method according to claim 60, wherein membrane is an amphiphilic layer or comprises a solid state layer.

### Claim 62 (depends on 60)

A method according to claim 60, wherein the target analyte is coupled to the membrane before it is contacted with the pore.

### Claim 63 (depends on 60)

A method according to claim 60, wherein the target analyte is attached to a microparticle which delivers the analyte towards the membrane.

### Claim 64

A method of forming a sensor for characterising a target polynucleotide, comprising forming a complex between a CsgG pore or a mutant thereof and a polynucleotide binding protein and thereby forming a sensor for characterising the target polynucleotide.

### Claim 65 (depends on 64)

A method according to claim 64, wherein the complex is formed by (a) contacting the pore and the polynucleotide binding protein in the presence of the target polynucleotide and (a) applying a potential across the pore.

### Claim 66 (depends on 65)

A method according to claim 65, wherein the potential is a voltage potential or a chemical potential.

### Claim 67 (depends on 64)

A method according to claim 64, wherein the complex is formed by covalently attaching the pore to the protein.

### Claim 68

A sensor for characterising a target polynucleotide, comprising a complex between a CsgG pore or a mutant thereof and a polynucleotide binding protein.

### Claim 69

Use of a CsgG pore or a mutant thereof to determine the presence, absence or one or more characteristics of a target analyte.

### Claim 70

A kit for characterising a target analyte comprising (a) a CsgG pore or a mutant thereof and (b) the components of a membrane.

### Claim 71

An apparatus for characterising target analytes in a sample, comprising (a) a plurality of a CsgG pores or mutants thereof and (b) a plurality of membranes.

### Claim 72 (depends on 71)

An apparatus according to claim 71, wherein the apparatus comprises:
a sensor device that is capable of supporting the plurality of pores and membranes being operable to perform analyte characterisation using the pores and membranes; and
at least one port for delivery of the material for performing the characterisation.

### Claim 73 (depends on 72)

An apparatus according to claim 72, wherein the apparatus comprises:
a sensor device that is capable of supporting the plurality of pores and membranes being operable to perform analyte characterisation using the pores and membranes; and
at least one reservoir for holding material for performing the characterisation.

### Claim 74 (depends on 72, 73)

An apparatus according to claim 72 or 73, wherein the apparatus further comprises:
a fluidics system configured to controllably supply material from the at least one reservoir to the sensor device; and
a plurality of containers for receiving respective samples, the fluidics system being configured to supply the samples selectively from the containers to the sensor device.

### Claim 75

A method of characterising a target polynucleotide, comprising:
a) contacting the polynucleotide with a CsgG pore or a mutant thereof, a polymerase and labelled nucleotides such that phosphate labelled species are sequentially added to the target polynucleotide by the polymerase, wherein the phosphate species contain a label specific for each nucleotide; and
b) detecting the phosphate labelled species using the pore and thereby characterising the polynucleotide.

### Claim 76 (depends on 31, 40)

A method of producing a mutant monomer according to claim 31, comprising expressing a polynucleotide according to claim 40 in a suitable host cell and thereby producing a mutant monomer according to claim 31.
